Skip to main content
Veterinary Medicines

Oxyglobin 130 mg/ml - Solution for infusion

Authorised
  • Hemoglobin glutamer-200, bovine

Product identification

Medicine name:
Oxyglobin 130 mg/ml - Solution for infusion
Active substance:
  • Hemoglobin glutamer-200, bovine
Target species:
  • Dog
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Hemoglobin glutamer-200, bovine
    16.20
    gram(s)
    /
    1.00
    Bag
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05AA10
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Infusion bag (polyolefin), Package_size:1 infusion bag (250 ml), Content:125 ml
  • Packaging:Infusion bag (polyolefin), Package_size:1 infusion bag (250 ml), Content:60 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • OPK Biotech Netherlands BV
Marketing authorisation date:
Manufacturing sites for batch release:
  • DALES PHARMACEUTICALS LIMITED
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 18/11/2022
Download
Bulgarian (PDF)
Published on: 18/11/2022
Croatian (PDF)
Published on: 18/11/2022
Czech (PDF)
Published on: 18/11/2022
Danish (PDF)
Published on: 18/11/2022
Dutch (PDF)
Published on: 18/11/2022
Estonian (PDF)
Published on: 18/11/2022
Finnish (PDF)
Published on: 18/11/2022
French (PDF)
Published on: 18/11/2022
German (PDF)
Published on: 18/11/2022
Greek (PDF)
Published on: 18/11/2022
Hungarian (PDF)
Published on: 18/11/2022
Icelandic (PDF)
Published on: 18/11/2022
Italian (PDF)
Published on: 18/11/2022
Latvian (PDF)
Published on: 18/11/2022
Lithuanian (PDF)
Published on: 18/11/2022
Maltese (PDF)
Published on: 18/11/2022
Norwegian (PDF)
Published on: 18/11/2022
Polish (PDF)
Published on: 18/11/2022
Portuguese (PDF)
Published on: 18/11/2022
Romanian (PDF)
Published on: 18/11/2022
Slovak (PDF)
Published on: 18/11/2022
Slovenian (PDF)
Published on: 18/11/2022
Spanish (PDF)
Published on: 18/11/2022
Swedish (PDF)
Published on: 18/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."